BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9525307)

  • 1. Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy.
    Lee YL; Tao MH; Chow YH; Chiang BL
    Hum Gene Ther; 1998 Mar; 9(4):457-65. PubMed ID: 9525307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma.
    Lee YL; Ye YL; Yu CI; Wu YL; Lai YL; Ku PH; Hong RL; Chiang BL
    Hum Gene Ther; 2001 Nov; 12(17):2065-79. PubMed ID: 11747597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.
    Bramson J; Hitt M; Gallichan WS; Rosenthal KL; Gauldie J; Graham FL
    Hum Gene Ther; 1996 Feb; 7(3):333-42. PubMed ID: 8835220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and eukaryotic expression of recombinant porcine single-chain interleukin-12].
    Wang XM; Yuan YY; Fang Q; Xia H; Sun X; Li BQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1687-92. PubMed ID: 22027768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
    Zhang J; Asselin-Paturel C; Bex F; Bernard J; Chehimi J; Willems F; Caignard A; Berglund P; Liljeström P; Burny A; Chouaib S
    Gene Ther; 1997 Apr; 4(4):367-74. PubMed ID: 9176524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems.
    McMonagle EL; Taylor S; van Zuilekom H; Sanders L; Scholtes N; Keanie LJ; Hopkins CA; Logan NA; Bain D; Argyle DJ; Onions DE; Schijns VE; Nicolson L
    Equine Vet J; 2001 Nov; 33(7):693-8. PubMed ID: 11770992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo.
    Lieschke GJ; Rao PK; Gately MK; Mulligan RC
    Nat Biotechnol; 1997 Jan; 15(1):35-40. PubMed ID: 9035103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction, eukaryotic expression and biological activities of a recombinant human single chain interleukin-12 fusion gene].
    Zhang M; Si L; Jin L; Wang Y; Geng Y
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):636-40. PubMed ID: 11877038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA.
    Saldarriaga OA; Perez LE; Travi BL; Melby PC
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):377-88. PubMed ID: 16386313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
    Lieu FH; Hawley TS; Fong AZ; Hawley RG
    Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A balanced expression of two chains of heterodimer protein, the human interleukin-12, improves high-level expression of the protein in CHO cells.
    Liu W; Wei H; Liang S; Zhang J; Sun R; Tian Z
    Biochem Biophys Res Commun; 2004 Jan; 313(2):287-93. PubMed ID: 14684158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
    Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
    J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.
    Heufler C; Koch F; Stanzl U; Topar G; Wysocka M; Trinchieri G; Enk A; Steinman RM; Romani N; Schuler G
    Eur J Immunol; 1996 Mar; 26(3):659-68. PubMed ID: 8605935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen-reactive Th1 development in IL-12-deficient mice.
    Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.